Table 1.
Physical characteristics and biochemical measurements of COVID-19 patients related to survival and mortality.
| COVID-19 Patients |
COVID-19 Survivors |
COVID-19 Non-survivors |
||
|---|---|---|---|---|
| Median (IQR) (n = 127) |
Median (IQR) (n = 111) |
Median (IQR) (n = 16) |
Pa | |
| Age (years) | 69 (59–80) | 68 (56–77) | 84 (70–88) | 0.001 |
| Male, n (%) | 75 (59.1) | 66 (59.5) | 9 (56.3) | 0.807 |
| BMI (kg/m2) | 28.2 (25.7–31.8) | 28.4 (25.8–32.4) | 26.0 (24.8–30.1) | 0.042 |
| PhA (°) | 4.4 (3.2–5.4) | 4.5 (3.5–5.5) | 2.8 (2.08–3.68) | <0.001 |
| SPhA | −0.8 (−2.0–0.2) | −0.7 (−1.8–0.3) | −2.95 (−3.6–−1.3) | <0.001 |
| R/H (Ω/m) | 302.5 (272.2–366.3) | 301.7 (272.2–363.5) | 334.6 (251.5–370.3) | 0.769 |
| Xc/H (Ω/m) | 24.7 (16.3–31.1) | 25.3 (18.9–32.4) | 15.0 (10.5–22.6) | 0.001 |
| BCM (kg) | 21.4 (16.3–27.9) | 23 (18.5–31.5) | 14.2 (10.2–18.0) | <0.001 |
| Hydration (%) | 73.8 (73.3–84.3) | 73.7 (73.2–82.1) | 85.2 (76.9–89.3) | 0.001 |
| Lymphocytes | 1520 (910–1960) | 1590 (980–2040) | 755 (543–1195) | <0.001 |
| CRP (mg/L) | 16.7 (5.0–59.9) | 14.3 (4.2–44.7) | 97.5 (24.4–199.6) | <0.001 |
| Fibrinogen (mg/dL) | 401.8 (307.5–514.5) | 384.2 (305–512.2) | 498⋅6 (399.9–790.4) | 0.032 |
| INR | 1.06 (1.01–1.14) | 1.06 (0.99–1.13) | 1⋅14 (1.05–1.53) | 0.004 |
| D-dimer (ng/mL) | 1211 (658.8–2860.5) | 1156 (583–2571) | 1758 (1074–3584) | 0.179 |
| Ferritin (ng/mL) | 482 (254.7–933.6) | 455.6 (247.8–917.3) | 486.5 (314.7–955.1) | 0.562 |
| Pre-albumin (mg/dL) | 18.8 (11.9–26.2) | 19 (14.35–27.9) | 8.3 (7–17.7) | 0.005 |
| CRP/Pre-albumin | 0.19 (0.02–0.59) | 0.09 (0.02–0.31) | 1.19 (0.24–3.22) | 0.002 |
a
P for comparison of non-survivors and survivors. IQR: interquartile range; PhA: phase angle; SPhA: standardized phase angle; R/H: Resistance/height; Xc/H: reactance/height; BMI body mass index; FFM: fat free mass; FM: fat mass; BCM: body cell mass; ECW: extracellular water; CRP: C-reactive protein; INR: International normalized ratio.